Clinical Trials Browser

Phase NA × lopinavir-ritonavir drug combination × Clear all

NCT04394182 2022-03-29

ULTRA-COVID

Phase NA Suspended

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome